Audio
Archive
2013
January
February
March
April
May
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Jul. 25, 2008
A New Direction for AIDS Vaccine Research
Click 
to enlarge images
to enlarge images
|
|
Tweet |
| The National Institutes of Health has decided to cancel a large-scale test of an experimental AIDS vaccine, saying that more focused research was needed on the way such vaccines interact with the immune system before the trial, known as PAVE 100, could proceed. The PAVE trial was designed to include over 8500 people. The vaccine to be tested was similar in some regards to a vaccine developed by pharmaceutical company Merck that failed in a study last fall. Both vaccines, rather than preventing infection, were designed to stimulate an immune response that would help infected individuals to keep HIV levels in check within the bloodstream. In this segment, Ira talks with Dr Anthony Fauci, head of the National Institute on Allergy and Infectious Diseases, about the decision not to proceed with the large PAVE 100 study. What challenges do researchers need to work out to be able to produce and effective AIDS vaccine? |
Produced by Charles Bergquist, Director and Contributing Producer
Guests
-
Anthony Fauci
Director, National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health
Bethesda, Maryland
FEATURED READING
Brilliant Blunders
by Mario Livio
ADVERTISEMENT
RELATED BLOG POSTS
- Predicting Storms, Electroshock Therapy, Germaphiles, and More
Each week we’ll round up links to science stories or studies that blow our mind, tickle our funny bone, or generally strike our ...
- Brilliant Blunders
Were the theories of illustrious minds such as Linus Pauling and Albert Einstein free of serious blunders? Absolutely not!
- Meet Susan Barry, Neurobiologist and 3D Visionary
Susan Barry could only see in two dimensions until age 48, when her life changed forever.
- Science Standards for the Next Generation
Newly released science standards expect students to be capable of designing experiments and making evidence-based arguments.
Discussion